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Abstract
Objective
To assess the added value of arterial enhancement fraction (AEF) color maps for the differ-
entiation of small metastases from hepatic benign lesions.
Subjects and Methods
We retrospectively analyzed 46 patients with colorectal cancer who underwent multiphasic
liver CT imaging and had low-attenuating liver lesions smaller than 3 cm (123 total lesions;
metastasis: benign = 32:91). AEF color maps of the liver were created from multiphasic liver
CT images using dedicated software. Two radiologists independently reviewed multiphasic
CT image sets alone and in combination with image sets with AEF color maps using a five-
point scale. The additional diagnostic value of the color maps was assessed by means of re-
ceiver-operating characteristic (ROC) analysis.
Results
The area under the ROC curve (Az) increased when multiphasic CT images were
combined with AEF color map analysis as compared with evaluation based only on multi-
phasic CT images (from 0.698 to 0.897 for reader 1, and from 0.825 to 0.945 for reader 2;
P< 0.001 and 0.002, respectively). The increase Az was especially significant for lesions
less than 1 cm (from 0.702 to 0.888 for reader 1, and from 0.768 to 0.958 for reader 2;
P = 0.001 and P = 0.001, respectively). The mean AEF of tumor-adjacent parenchyma
(35.07 ± 27.2) was significantly higher than that of tumor-free liver parenchyma (27.3 ± 20.6)
(P = 0.04).
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Conclusions
AEF color mapping can improve the diagnostic performance for small hepatic metastases
from colorectal cancer and may allow for the elimination of additional examinations.
Introduction
The liver is the most common site of metastasis from colorectal cancer. Accurate preoperative
diagnosis of liver metastases is critical for planning treatment and predicting prognosis [1,2].
Computed tomography (CT) is the primary imaging modality for preoperative evaluation of
patients with known or suspected colorectal cancer and can be used to accurately diagnose
both the extent of primary colorectal cancer and liver metastasis. Small, low-attenuation lesions
in the liver were detected in 13% to 25.5% of preoperative CT scans, although only 2.2% to
14.0% were confirmed as metastases [3,4]. It is often difficult to characterize such small hepatic
lesions on CT images. Although gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid
(Gd-EOB-DTPA)-enhanced magnetic resonance image (MRI) and positron emission tomog-
raphy (PET) can be helpful for the diagnosis of small metastases, [5–7] these imaging modali-
ties require additional expense and time and are not available in some facilities or countries.
Arterial enhancement fraction (AEF) color mapping can reveal hemodynamic changes in
liver parenchyma. The AEF is defined as the ratio of the attenuation increment during the arte-
rial and portal venous phases compared with the unenhanced image (AEF = [(HUA—HUU)/
(HUP—HUU)], where HU is the attenuation, A is the arterial phase, P is the portal venous
phase, and U is the non-contrast image [8]. Hepatic hemodynamic changes have been shown
to precede definite liver metastasis and higher enhancement of liver between 25 and 40 sec can
suggest occult liver metastasis [9,10]. AEF color mapping is also helpful for predicting tumor
response to chemotherapy [11], and could improve the diagnostic performance for focal liver
lesions such as HCC [8].
We hypothesized that semi-quantitative evaluation of small liver lesions and quantitative
comparison of lesion-adjacent and lesion-free liver parenchyma with AEF color mapping may
also improve the diagnostic performance for differentiating small liver metastases from hepatic
cysts. The major advantage of AEF color mapping is that it is a pure post-processing technique,
and could therefore be carried out using routine dynamic CT data without additional radiation
or other imaging studies. The purpose of this study was to investigate the diagnostic value of
the AEF for the differentiation of small hepatic metastases from benign hepatic cysts in patients
with colorectal cancer.
Materials and Methods
Patients
We obtained approval for this retrospective study from the Institutional Review Board, and the
requirement for informed consent was waived. We retrospectively reviewed electronic medical
records and radiologic reports from between April 2009 and May 2011. Patients who had colo-
rectal cancer and who underwent multiphasic CT including precontrast, arterial phase, and
portal venous phase were included in the study. Patients who had hepatic metastases larger
than 30 mm were excluded, because large liver metastases can easily be diagnosed as metasta-
ses, whereas the aim of our study was to evaluate the added value of AEF for detecting small he-
patic metastases. Patients who underwent thermal ablation therapy for hepatic lesions were
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excluded as well to avoid misdiagnoses of standard references. Patients who had more than
eight liver metastases or who had a history of any prior treatment for liver metastasis were also
excluded from the study. In addition to histopathologic confirmation, all patients had under-
gone follow-up contrast-enhanced CT or MRI. Determination of metastasis was based on ei-
ther histopathology or imaging surveillance. Without histopathologic reports, liver metastasis
was confirmed when: 1) the lesion showed typical metastatic imaging findings [12–14]; and
2) interval size change was seen on serial imaging. Cysts were diagnosed based on typical imag-
ing findings such as bright hyper-intensity on T2-weighted images and no enhancement on
dynamic contrast-enhanced T1-weighted images or were diagnosed as such being water-
attenuating lesions without growth in at least 12 months of follow-up on MDCT, MRI, or a
combination of MDCT and MRI.
CT Acquisition
CT examinations were performed using multidetector CT scanners (Somatom Sensation 16,
Sensation 64, or Somatom Definition Flash; Siemens Medical Solutions, Forchheim, Germany).
The scanning parameters were as follows: 120-kV; 240 reference mAs, slice thickness, 3 mm,
and table speed of 18.64–26.75 mm/rotation (pitch 0.6–1.07). The field-of-view size was
adapted to each individual’s physique. A medium smooth convolution kernel (B30f) was used.
A precontrast scan was obtained before administration of 2.0 mL/kg of nonionic contrast mate-
rial (iopromide, Ultravist 300, Bayer Schering Palmar), followed by a 20-mL saline chaser bolus
injected at a fixed injection duration of 30 seconds. Using a bolus-tracking technique, the late
arterial phase scan was started 18 seconds after the Hounsfield Units (HU) in the abdominal
aorta reached 100 HU. The portal venous phase scan was obtained 35 seconds after the end of
the arterial phase scan.
Color mapping of the liver AEF
The CT data set was transferred to a workstation (Leonardo; Siemens Medical Solutions, Er-
langen, Germany), and a quantitative AEF map of the whole liver was created using dedicated
software (Hepacare; Siemens Medical Solutions) as previously described [11,15]. Briefly, the
three-phase data sets were precisely aligned in three dimensions by non-rigid warping tech-
niques to correct the mismatches in the breath-hold images [8]. During registration, the unen-
hanced image is used as a reference, and the arterial and portal phase CT images are registered
on unenhanced phase CT images. Unenhanced CT images are then subtracted from the arterial
and portal venous phase images and AEF percentages, i.e., the ratio of the absolute increment
of attenuation on the arterial phase to that of the portal phase multiplied by 100, are mapped
on the color map pixel by pixel (color map scale: purple, 0%; red, 100%) [8].
Image analysis
Two radiologists (C.W.S and K.K.A with 6 and 5 years of experience in abdominal radiology,
respectively) independently analyzed the multiphasic CT image sets. To avoid any possible re-
call bias, they analyzed the combined image sets six weeks later. The first image set consisted of
unenhanced, arterial, and portal phase images, and the second image set was a combined
image set of the AEF maps of the liver and multiphasic CT images. The observers were aware
of the overall goal of the study before the review and knew that the patients had been diagnosed
with colorectal cancer. The first and second image sets were reviewed in stack mode using the
picture archiving and communication system (PACS). All observers were asked to record the
number, size, and segment of the lesions and to grade them by level for the diagnosis of liver
metastasis. Size was assessed by measuring the maximum diameter of the lesion on a transverse
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CT image. The diagnostic confidence for each lesion was scored according to a five-point scale:
Score of 1 = definite benign lesion; score of 2 = probably benign lesion; score of 3 = possible
metastasis; score of 4 = probably metastasis; and a score of 5 = definite metastasis. Observers
were aware that, for statistical analyses, scores of 4–5 would be considered indicative of meta-
static lesions and a score of 3 would be considered indicative of a lesion which needs further in-
vestigation by liver MRI to differentiate hepatic metastasis from benign hepatic cyst. If there
was a mismatch between the CT and AEF color map during evaluation of the second image
sets, the lesion was rated as score 3. The diagnostic criteria for hepatic cyst (Fig. 1) and liver
metastasis (Fig. 2) by CT and AEF color mapping are summarized in Table 1 [11,16,17].
Quantitative analysis of AEF values
AEF values were quantitated in both benign-lesion-adjacent parenchyma and metastatic-
tumor-adjacent parenchyma. Lesion-adjacent liver parenchyma was defined as normal liver
parenchyma which contained hepatic metastasis or a cyst in the same segment. Region of inter-
ests (ROIs) were drawn manually in each segment without including the lesion itself or major
visible vessels. If the patient had both metastasis and hepatic cyst in the same segment, it was
considered metastasis-adjacent liver parenchyma.
Statistical Analysis
All statistical analyses were performed by a medical statistician. Comparison of the mean AEF
values of tumor-adjacent and benign-lesion—adjacent parenchyma were carried out by the
Fig 1. A 64-year-old female patient with sigmoid colon cancer showed a tiny low-attenuating lesion in
the S8 of the liver on a dynamic CT scan (A–C). Because this lesion showed no interval change for 2 years
on follow-up imaging studies and presented as a high SI lesion on T2-weighted MR images, it was diagnosed
as a hepatic cyst. The AEF color map presented the lesion as a nodule (arrow) with decreased AEF (D).
doi:10.1371/journal.pone.0114819.g001
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independent- sample t-test. P values less than 0.05 were considered statistically significant. The
analysis was performed using SAS software (version 9.2, Cary, NC, USA). For imaging inter-
pretation, ROC analysis was performed using SPSS software (PASW Statistics, version 20;
SPSS, Chicago, IL, USA). Interobserver agreement was evaluated using Cohen kappa (k) statis-
tics. A k-value of 0–0.20 indicated slight agreement; 0.21–0.40, fair agreement; 0.41–0.60, mod-
erate agreement; 0.61–0.80, substantial agreement; and 0.81–1.00, almost perfect agreement
[18]. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV),
Fig 2. A 68-year-old male patient who was diagnosed with rectosigmoid colon cancer had a low
attenuating focal lesion in the S5 of the liver on dynamic CT (A–C). Note that the lesion-adjacent
parenchyma also exhibited increased AEF (green) on the AEF color map (D). The lesion was confirmed to be
metastatic adenocarcinoma from the histopathologic report.
doi:10.1371/journal.pone.0114819.g002
Table 1. CT and AEF color map diagnostic criteria for the assessment of focal hepatic lesions.
CT AEF color map
Hepatic
metastasis
Low- or iso-attenuating
masses with rim enhancement
Increased AEF value of the whole lesion or
peripheral portion of the lesion, compared with liver
parenchyma[11]
Irregular margin or central
necrosis
Increased AEF value of lesion-adjacent parenchyma
compared with tumor-free parenchyma
Incomplete centripetal
enhancement pattern
Hepatic cyst Water attenuation (0–10 HU) Close to 0% (purple color) or 0% (defect on AEF map)
No enhancement No increased AEF value of lesion-adjacent liver
parenchyma, compared with lesion-free liver
parenchyma
Imperceptible wall
CT, computed tomography; AEF, arterial enhancement fraction; HU, Hounsﬁeld unit.
doi:10.1371/journal.pone.0114819.t001
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and accuracy of diagnostic performance were compared using logistic regression with the gen-
eralized estimating equation (GEE) method [19].
Results
Patients
Forty-six patients (mean age, 60.8 years ± 11.4 [standard deviation]), 32 men (mean age,
60.3 years ± 10.4) and 14 women (mean age, 62.1 years ± 13.7), were included in the study.
There were a total of 123 lesions and, among them, 32 (26.0%) lesions were hepatic metastases
and 91 (74.0%) were benign. Overall, 16 (34.8%) patients had hepatic metastasis and 6 (13.0%)
of them had both metastasis and hepatic cysts. Among 32 hepatic metastases (11.8 ± 6.6 mm),
there were 19 lesions less than 10 mm in diameter (7.2 ± 1.7 mm), and 13 lesions more than
10 mm in diameter (18.5 ± 5.0 mm). In 91 hepatic cysts (6.6 ± 3.8 mm), 84 lesions were less
than 10 mm in diameter (5.6 ± 1.6 mm), and 7 lesions more than 10 mm in diameter (18.2 ±
3.8 mm). A final diagnosis was established by histopathology for 22 metastatic lesions in 11 pa-
tients and by serial imaging studies for 10 lesions in 5 patients. For 10 metastatic lesions in
5 patients, following imaging studies were done with a combination of MDCT (follow up inter-
val: 27.0 ± 17.0 months) and MRI at 12-month intervals. Cysts were diagnosed based on
follow-up MDCT (n = 9), MRI (n = 3), or a combination of MDCT and MRI (n = 24) with a
mean follow up interval of 32.3 ± 15.4 months.
Diagnostic performance of AEF color maps
The mean value of the area under the ROC curve (Az) increased when multiphasic CT images
and AEF color maps combined were compared with evaluation based only on multiphasic CT
images from 0.698 to 0.897 (reader 1) and from 0.825 to 0.945 (reader 2) (P value< 0.001 and
0.002, respectively). This increase was especially significant for lesions less than 1 cm in diameter,
increasing from 0.702 to 0.888 (reader 1) and from 0.768 to 0.958 (reader 2) (P value = 0.001 and
0.001, respectively). The difference in the mean Az value of lesions of more than 1 cm in diame-
ter was not statistically significant (Table 2).
The diagnostic performance is summarized in Table 3. The accuracy of using combined image
sets including AEF color maps was significantly higher compared with using only multiphasic CT
for both readers (P values 0.001 and 0.013). This increase in accuracy with the combined image
Table 2. Area under the receiver-operating characteristic curve of multiphasic CT and AEF color maps for the detection of colorectal liver
metastases according to size.
Reader 1 Reader 2
AZ value P value AZ value P value
All lesions <0.001 0.002
CT 0.698 ± 0.0258 0.825 ± 0.0412
CT+AEF color map 0.897 ± 0.2285 0.945 ± 0.0165
<1cm 0.001 0.001
CT 0.702 ± 0.0269 0.768 ± 0.0591
CT+AEF color map 0.888 ± 0.0403 0.958 ± 0.0152
1cm 0.143 0.071
CT 0.643 ± 0.0922 0.714 ± 0.1010
CT+AEF color map 0.786 ± 0.1010 0.786 ± 0.1010
Az, the area under the receiver-operating characteristic curve; CT, computed tomography; AEF, arterial enhancement fraction.
doi:10.1371/journal.pone.0114819.t002
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sets was also higher for lesions less than 1 cm in diameter (P value =< 0.001 and 0.021 for two
readers). However, for lesions exceeding 1 cm in diameter, the accuracy was higher or at least the
same when CT was combined with color maps compared with multiphasic CT, but the difference
was not statistically significant (P values = 0.158 and 0.318 for two readers)
There were two false-negative lesions in two patients that were not verifiable on the AEF
color maps but were verifiable on multiphasic CT. A retrospective review of these lesions re-
vealed that they measured 4 mm and 6 mm in diameter, but their location at the liver dome
may have resulted in mismatches in the multiphase images due to patient breathing. There
were five false-positive lesions in three patients that had been rated either 1 or 2 by multiphasic
CT and were later rated 3 or 4 with the AEF color map. All three patients showed mismatches
in the multiphase images due to poor breath holding, and two of the five lesions were located
adjacent to the diaphragm.
Quantitative color mapping of liver AEF
In 46 patients, there were 63 benign-lesion-adjacent parenchyma and 28 metastatic-tumor-ad-
jacent parenchyma. The mean AEF value of metastatic-tumor-adjacent parenchyma (35.1 ±
27.2) was significantly higher than that of benign-lesion-adjacent parenchyma (22.8 ± 19.4)
(P value = 0.016).
Interobserver Agreement
For multiphasic CT imaging, the k value for the two observers was 0.274, indicating fair inter-
observer agreement, but the k value dropped to 0.180 when the lesion was less than 1 cm.
When combined with color mapping of the hepatic AEF, the k value for all lesions was 0.766,
indicating good agreement, and even for lesion less than 1 cm, the k value was 0.721 (Table 4).
Table 3. Diagnostic performance of hepatic metastasis detection on multiphasic CT and AEF color maps.
Reader and Lesion Reader 1 Reader 2
<1cm 1cm Total <1cm 1cm Total
(n = 103) (n = 20) (n = 123) (n = 103) (n = 20) (n = 123)
Sensitivity (%) CT 100 100 100 63.2 100 78.1
CT+AEF map 89.5 100 93.8 100 100 100
P value 0.158 > 0.999 0.158 0.008 > 0.999 0.008
Speciﬁcity (%) CT 40.5 28.6 39.6 90.5 42.9 86.8
CT+AEF map 88.1 57.1 85.7 91.6 57.1 89
P value <0.001 0.166 <0.001 0.655 0.319 0.414
Accuracy (%) CT 51 75 55.3 85.3 85 84.6
CT+AEF map 88.2 85 87.8 93.1 85 91.9
P value <0.001 0.158 <0.001 0.021 0.318 0.013
PPV (%) CT 27.5 72.2 36.8 60 76.5 67.6
CT+AEF map 63 81.3 69.8 73.1 81.3 76.2
P value <0.001 0.158 <0.001 0.13 0.318 0.1
NPV (%) CT 100 100 100 91.5 100 91.9
CT+AEF map 97.3 100 97.5 100 100 100
P value 0.158 >0.999 0.158 0.008 >0.999 0.008
CT, computed tomography; AEF, arterial enhancement fraction.
doi:10.1371/journal.pone.0114819.t003
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Discussion
Our results suggest that the diagnostic performance for small hepatic metastases in patients
with colorectal cancer, especially for lesions less than 1 cm in size, can be improved by com-
bined review of CT images and AEF color mapping. The interobserver agreement between two
readers was also improved after adding AEF color mapping. The AEF value was significantly
higher in metastatic-tumor-adjacent parenchyma than in lesion-free liver parenchyma.
For patients with hepatic metastases from colorectal cancer, the prognosis is better with sur-
gical removal or percutaneous ablation of the hepatic metastases [20]. Thus, accurate diagnosis
of hepatic metastasis is important. Although CT is the primary diagnostic tool for preoperative
evaluation and postoperative surveillance, MRI showed better diagnostic performance in char-
acterization of small hepatic metastases [21,22]. State-of-the-art MDCT uses beam collimation
of less than 1 mm, but image reconstruction in these studies involved images with 3 mm or
5 mm collimation. This could have resulted in ill-defined margins or pseudoenhancement and
a decrease in diagnostic accuracy and interobserver agreement, especially in lesions less than
1 cm in size. Furthermore, with inherent high tissue contrast and hepatocyte-specific contrast
agent or diffusion-weighted images, liver MRI can allow for high diagnostic accuracy (Az
value, 0.965) and high sensitivity (97.4%), even with small hepatic metastases [7,13]. Conse-
quently, additional MRI after abdominal CT scan can assist in the characterization of small
liver lesions [21], despite being both time-consuming and expensive. In our study, the diagnos-
tic performance of combined sets of quantitative AEF color mapping and multiphasic CT im-
ages (Az value, 0.888 and 0.958) was higher than that of CT only (Az value, 0.78) and close to
that of liver MRI (Az value, 0.96) [21]. Furthermore, interobserver agreement was also im-
proved after combined review of CT images and AEF color maps. Considering that AEF color
maps can be obtained from existing CT images without additional time or expense, they could
easily be used in daily clinical practice before performing other diagnostic imaging modalities.
Perfusion imaging of the liver is known to have the potential to improve the early detection
of regional liver disease, including hepatic metastasis through the resolution of hepatic arterial
and portal venous components [23]. In the presence of metastasis, an increase in hepatic arteri-
al perfusion compared with total hepatic perfusion has been reported [24–26]. However, al-
though perfusion CT could provide additional information for the diagnosis of metastasis, it
could not be used in a clinical setting due to the relatively high radiation exposure during ex-
amination [23]. When used as a post-processing technique, quantitative measurement of he-
patic AEF has the potential to replace perfusion imaging, since the AEF of tumor-adjacent
parenchyma is higher than that of lesion-free liver parenchyma without the need for additional
radiation exposure [11]. We similarly found that the AEF of tumor-adjacent parenchyma was
higher than that of benign-adjacent and lesion-free parenchyma. [4,27]
Although previous studies have not specifically described false-positive and false-negative
diagnoses [8,11,27], two false-negative and five false-positive diagnoses were made in our
study. The three-dimensional non-rigid warping techniques used by the Hepacare software to
align three-phase image data sets might not have been sufficient to correct data mismatch in
Table 4. k values for interobserver agreement.
Observer Comparison CT CT+AEF map P value
All 0.274 0.766 <0.001
Size < 1 cm 0.18 0.721 <0.001
CT, computed tomography; AEF, arterial enhancement fraction.
doi:10.1371/journal.pone.0114819.t004
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the liver dome, which is the most vulnerable to diaphragm and heart motion. Hence, applica-
tion and interpretation of AEF color mapping needs to be carried out with caution in patients
who cannot hold their breath well or in patients who have lesions in the liver dome.
Our study had some limitations. First, it was a retrospective study based on analysis of med-
ical records, thus selection bias might exist. Second, the study population was relatively small.
Third, only hypovascular metastases were evaluated. Forth, the benign lesions only included
hepatic cysts. Other benign lesions such as small hemangioma, hamartoma, or granuloma
could also have been present. However, the relatively low incidence of other benign lesions
compared with hepatic cysts suggests that our results may be applicable in daily practice. Fifth,
as mentioned above, there were two false-negative and five false-positive diagnoses made on
the AEF color map, and these misdiagnoses were mainly due to data mismatch caused from
motion artifacts. Thus, the added value of a AEF color map can be limited especially for lesions
located at the liver dome, which is vulnerable to diaphragm and heart motion. Sixth, only 22 le-
sions among the total 123 lesions were confirmed through pathologic reports while the final di-
agnosis of the remaining 121 lesions were made based on 1-year follow up imaging studies.
Previous studies with small hepatic metastases showed high diagnostic performances of gado-
linium-EOB-DTPA enhanced and diffusion-weighted MRI with Az values ranging from 0.926
to 0.983 but they also reported false positive and negative cases and this might cause wrong di-
agnoses of standard references. [7,13] Hence, although this might be true for very few cases,
there is a possibility of wrong diagnosis on MR. However, this study had a follow up period of
at least 12 months and this is thought to have minimized the risk of misdiagnosis. Seventh and
last, there was a 6-week interval between the two imaging analysis sessions to avoid recall bias
but this method of evaluating the true added value of AEF color mapping might have its
own limitations.
In conclusion, AEF color mapping can allow improvement of diagnostic performance for
the differential diagnosis of small colorectal hepatic metastases from hepatic cysts, especially in
lesions less than 1 cm in diameter, without additional radiation exposure.
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